Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C H Polman

Showing results (231-240 of 290) with videos related to

Pageof 29
Sort By:
Neurology|December 11, 2002
Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesionsE Bergers, J C J Bot, C J A De Groot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2014
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosisL J Balk, M D Steenwijk, P Tewarie, et al.
Surgical Neurology|March 1, 1991
Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2J J Heimans, J Wagstaff, W O Schreuder, et al.
Neurology|May 16, 2002
Safety, tolerability, and efficacy of orally administered cannabinoids in MSJ Killestein, E L J Hoogervorst, M Reif, et al.
Journal of Neuroimmunology|July 6, 2002
The FAS-670 polymorphism influences susceptibility to multiple sclerosisT van Veen, N F Kalkers, J B A Crusius, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2006
Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily lifeF A H van der Linden, J J Kragt, J C Hobart, et al.
Neurology|August 28, 2002
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA regionB A de Jong, T W J Huizinga, E Zanelli, et al.
Journal of Neuroimmunology|May 1, 1996
A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosisB W van Oosten, M H Rep, R A van Lier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 2014
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathyA Vennegoor, T Rispens, B W Van Oosten, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIRR H Lazeron, D W Langdon, M Filippi, et al.
Pageof 29

Showing results (231-240 of 290) with videos related to

Sort By:
Pageof 29
Neurology|December 11, 2002
Axonal damage in the spinal cord of MS patients occurs largely independent of T2 MRI lesionsE Bergers, J C J Bot, C J A De Groot, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 29, 2014
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosisL J Balk, M D Steenwijk, P Tewarie, et al.
Surgical Neurology|March 1, 1991
Treatment of leptomeningeal carcinomatosis with continuous intraventricular infusion of recombinant interleukin-2J J Heimans, J Wagstaff, W O Schreuder, et al.
Neurology|May 16, 2002
Safety, tolerability, and efficacy of orally administered cannabinoids in MSJ Killestein, E L J Hoogervorst, M Reif, et al.
Journal of Neuroimmunology|July 6, 2002
The FAS-670 polymorphism influences susceptibility to multiple sclerosisT van Veen, N F Kalkers, J B A Crusius, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 6, 2006
Proxy measurements in multiple sclerosis: agreement between patients and their partners on the impact of multiple sclerosis in daily lifeF A H van der Linden, J J Kragt, J C Hobart, et al.
Neurology|August 28, 2002
Evidence for additional genetic risk indicators of relapse-onset MS within the HLA regionB A de Jong, T W J Huizinga, E Zanelli, et al.
Journal of Neuroimmunology|May 1, 1996
A pilot study investigating the effects of orally administered pentoxifylline on selected immune variables in patients with multiple sclerosisB W van Oosten, M H Rep, R A van Lier, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 1, 2014
Application of serum natalizumab levels during plasma exchange in MS patients with progressive multifocal leukoencephalopathyA Vennegoor, T Rispens, B W Van Oosten, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 30, 2000
Neuropsychological impairment in multiple sclerosis patients: the role of (juxta)cortical lesion on FLAIRR H Lazeron, D W Langdon, M Filippi, et al.
Pageof 29